Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
48,055,378
-
Share change
-
+991,497
-
Total reported value
-
$732,837,689
-
Price per share
-
$15.25
-
Number of holders
-
111
-
Value change
-
+$12,060,151
-
Number of buys
-
50
-
Number of sells
-
55
Institutional Holders of NGM BIOPHARMACEUTICALS INC - COM (NGM) as of Q1 2022
As of 31 Mar 2022,
NGM BIOPHARMACEUTICALS INC - COM (NGM) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,055,378 shares.
The largest 10 holders included
Column Group LLC, RHO CAPITAL PARTNERS INC, Point72 Asset Management, L.P., VANGUARD GROUP INC, BlackRock Inc., StepStone Group LP, Ponoi Management, LLC, Ponoi II Management, LLC, FMR LLC, and BVF INC/IL.
This page lists
111
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.